Comparison of the ocular microbiome between chronic Stevens-Johnson syndrome patients and healthy subjects
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- Thailand
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Conjunctival sac Conjunctiva serous sac,Subbrillar sac,Conjunctival sac,conjunctival sac
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Stevens-Johnson syndrome Dermatostomatitis, Stevens Johnson type,erythema multiforme Major,hypersensitivity syndrome, carbamazepine-induced, susceptibility to,severe cutaneous adverse reaction, susceptibility to,Stevens Johnson syndrome,Stevens-Johnson syndrome,Stevens-Johnson syndrome, susceptibility to,toxic Epidermal necrolysis, susceptibility to,stevens-Johnson syndrome
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- healthy controls
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Stevens-Johnson Syndrome
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Stevens-Johnson Syndrome patients
- Group 0 sample size Number of subjects in the control (unexposed) group
- 20
- Group 1 sample size Number of subjects in the case (exposed) group
- 20
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- Topical antibiotics within the 4 weeks prior to study entry were excluded
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- Mann-Whitney (Wilcoxon)
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- Matched on Factors on which subjects have been matched on in a case-control study
- age, sex
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
Signature 1
Source: Figure 1
Description: Figure 1. Significant difference of taxa abundance. This figure represents the significant difference of taxonomic level of each genus comparing between SJS patients and healthy subjects. We analyzed the proportion of each genus by Mann-Whitney U test. The p-value less than 0.05 was defined as statistically significant difference.
Abundance in Group 1: increased abundance in Stevens-Johnson Syndrome
Revision editor(s): Mary Bearkland
Signature 2
Source: Figure 1
Description: Figure 1. Significant difference of taxa abundance. This figure represents the significant difference of taxonomic level of each genus comparing between SJS patients and healthy subjects. We analyzed the proportion of each genus by Mann-Whitney U test. The p-value less than 0.05 was defined as statistically significant difference.
Abundance in Group 1: decreased abundance in Stevens-Johnson Syndrome
NCBI | Quality Control | Links |
---|---|---|
Shewanella | ||
Cohaesibacter | ||
Clostridium | ||
Fusibacter | ||
Tenacibaculum | ||
Methylophaga | ||
Cetobacterium | ||
Arcobacter | ||
Vibrio |
Revision editor(s): Mary Bearkland